J. Warram

A. Krolewski, J. Warram, G. Boner, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus.

J. Siegel, A. Krolewski, J. Warram, 1992, Journal of the American Society of Nephrology : JASN.

Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?

J. Xue, A. Krolewski, J. Warram, 2005, Kidney international.

Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

P. Eggers, J. Warram, M. Królewski, 1996, Kidney international.

Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy.

A. Krolewski, J. Warram, A. R. Christlieb, 1994, Kidney international. Supplement.

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.

R. Nelson, A. Krolewski, J. Warram, 2005, Journal of the American Society of Nephrology : JASN.

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2012, American journal of physiology. Renal physiology.

Hypertension: The Major Risk Factor in Juvenile-onset Insulin-dependent Diabetics

A. Krolewski, J. Warram, O. Ganda, 1981, Diabetes.

Genetic analysis of albuminuria in the aging mouse and concordance with loci for diabetic nephropathy found in a genome-wide association scan

R. Korstanje, S. Tsaih, M. Pezzolesi, 2010 .

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes

A. Galecki, J. Weinberg, A. Krolewski, 2010, Diabetes Care.

Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.

A. Krolewski, J. Warram, B. Perkins, 2008, Diabetes research and clinical practice.

Nephrotoxicity from angiographic contrast material. A prospective study.

R. Gleason, L. Weinrauch, J. D'Elia, 1982, The American journal of medicine.

The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus (Short Communication)

D. Moczulski, W. Grzeszczak, M. Zychma, 1999, Diabetologia.

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

A. Krolewski, J. Warram, B. Perkins, 2008, Journal of the American Society of Nephrology : JASN.

Early renal function decline in type 1 diabetes is associated with excess urinary excretion of markers of protein damage

Paul J Thornalley, A. Krolewski, N. Rabbani, 2008 .

Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.

J. Weinberg, A. Krolewski, J. Warram, 2007, Journal of the American Society of Nephrology : JASN.

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes

J. Klein, M. Merchant, A. Krolewski, 2013, Kidney international.

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes

A. Krolewski, N. Rabbani, A. Adaikalakoteswari, 2012, PloS one.

Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

B. Rovin, G. Page, J. Klein, 2009, Journal of the American Society of Nephrology : JASN.

Regression of microalbuminuria in type 1 diabetes.

Andrzej S Krolewski, A. Krolewski, J. Warram, 2003, The New England journal of medicine.

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes

J. Weinberg, A. Krolewski, J. Warram, 2009, Diabetes Care.

Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes

Stephen S. Rich, Lucia Mirea, Shelley B. Bull, 2009, Diabetes.

Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.

J. Skupień, A. Krolewski, J. Mychaleckyj, 2010, Seminars in nephrology.

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA1c in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

A. Galecki, J. Skupień, M. Małecki, 2014, Diabetes Care.

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus.

A. Krolewski, L. Laffel, J. Warram, 1995, The New England journal of medicine.

Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus.

J. Manson, A. Krolewski, J. Warram, 1995, The New England journal of medicine.

Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

A. Galecki, J. Skupień, A. Krolewski, 2014, Journal of the American Society of Nephrology : JASN.

Nephropathy in Type 1 Diabetes Is Diminished in Carriers of HLA-DRB1*04

P. Mueller, P. Cleary, J. Warram, 2007, Diabetes.

Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent diabetes mellitus and persistent proteinuria.

L. Laffel, J. Warram, O. Ganda, 1992, Journal of the American Society of Nephrology : JASN.

Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers.

A. Krolewski, C. R. Kahn, J. Warram, 1985, The New England journal of medicine.

Acute Insulin Secretion as a Predictor of Weight Gain in Healthy Humans

A. Goldfine, J. Warram, B. Martin, 2006, Obesity.

Factors Modifying the Risk of IDDM in Offspring of an IDDM Parent

A. Krolewski, J. Warram, M. C. Angelico, 1995, Diabetes.

Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.

A. Antonellis, A. Krolewski, J. Warram, 1998, Diabetes.

Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.

A. Krolewski, A. Doria, J. Warram, 1999, Diabetes care.

Identification of new mutations in the hepatocyte nuclear factor 4a gene among families with early onset Type 2 diabetes mellitus

A. Antonellis, A. Krolewski, J. Warram, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Study of glucose removal rate and first phase insulin secretion in the offspring of two parents with non-insulin-dependent diabetes.

A. Krolewski, J. Warram, B. Martin, 1988, Advances in experimental medicine and biology.

Effect of diet on excretion of estrogens in pre- and postmenopausal women.

J. Dwyer, H. Adlercreutz, B. Goldin, 1981, Cancer research.

Response to Comment on: Wanic et al. (2008) Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies: Diabetes 57:2547–2551, 2008

K. Wanic, A. Krolewski, J. Warram, 2008, Diabetes.

Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis.

D. Moczulski, A. Antonellis, A. Krolewski, 1998, Diabetes.

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus.

L. Rand, A. Krolewski, C. R. Kahn, 1987, The American journal of cardiology.

Excess mortality associated with diuretic therapy in diabetes mellitus.

A. Krolewski, L. Laffel, J. Warram, 1991, Archives of internal medicine.

Systemic hypertension, diabetes mellitus and the kidney.

A. Krolewski, J. Warram, A. R. Christlieb, 1987, The American journal of cardiology.

Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus.

D. Housman, A. Krolewski, A. Doria, 1992, Journal of the American Society of Nephrology : JASN.

Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor glycemic control, in patients with type I diabetes.

A. Krolewski, L. Laffel, J. Warram, 1989, Diabete & metabolisme.

Genetic factors and susceptibility to diabetic nephropathy.

W. Knowler, L. Rand, M. Steffes, 1988, New England Journal of Medicine.

Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease

R. Parker, A. Goldfine, C. R. Kahn, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes.

A. Krolewski, A. Doria, S. H. Kim, 2001, Journal of Clinical Endocrinology and Metabolism.

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

A. Krolewski, C. R. Kahn, J. Warram, 1990, Annals of internal medicine.

High-density SNP genome wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: Discordant sib-pair approach.

D. Moczulski, K. Wanic, A. Krolewski, 2008 .

The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)

Michael S. Reidy, Shawn S. Stephens, Bartholomew E. Clark, 2022, BMC Nutrition.

Novel Mutations and a Mutational Hotspot in the M0DY3 Gene

L. Groop, Lei Fang, C. Forsblom, 1997, Diabetes.

Acute Postchallenge Hyperinsulinemia Predicts Weight Gain: A Prospective Study

R. Sigal, A. Krolewski, J. Warram, 1997, Diabetes.

A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

P. Scherer, A. Berg, A. Doria, 2002, Diabetes.

Association of Metformin With the Development of Age-Related Macular Degeneration.

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, JAMA ophthalmology.

Impact of blood pressure on diabetic retinopathy.

A. Ziegler, A. Krolewski, J. Warram, 1989, Diabete & metabolisme.

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, Diabetes Care.

Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial.

J. D. Pozo-olano, J. Warram, J. de dios Pozo-Olano, 1978, Gastroenterology.

Uremic solutes and risk of end stage renal disease in type 2 diabetes

T. Meyer, J. Skupień, R. Mohney, 2014, Kidney international.

Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics.

A. Krolewski, A. Doria, J. Warram, 1995, Diabetes/metabolism reviews.

Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes.

A. Krolewski, A. Doria, J. Warram, 1999, Diabetes.

Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24.

S. Rich, T. Klupa, A. Krolewski, 2003, Diabetes.

Genetic Modifiers of the Age at Diagnosis of Diabetes ( MODY 3 ) in Carriers of Hepatocyte Nuclear Factor-1 Mutations Map to Chromosomes 5 p 15 , 9 q 22 , and 14 q 24

S. Rich, T. Klupa, A. Krolewski, 2003 .

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

R. N. Bergman, R. Bergman, A. Krolewski, 1992, The Lancet.

Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.

R. Sigal, A. Krolewski, A. Doria, 1996, The Journal of clinical endocrinology and metabolism.

A method for developing high-density SNP maps and its application at the type 1 angiotensin II receptor (AGTR1) locus.

D. Moczulski, A. Antonellis, A. Krolewski, 2002, Genomics.

Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes.

F. Hu, A. Doria, J. Warram, 2008, JAMA.

Diabetes susceptibility at IDDM2 cannot be positively mapped to the VNTR locus of the insulin gene

A. Krolewski, A. Doria, J. Warram, 1996, Diabetologia.

A newly identified mutation in an IPF1 binding site of the insulin gene promoter may predispose to type 2 diabetes mellitus

A. Krolewski, P. Lebrun, M. Pezzolesi, 2006, Diabetologia.

Examination of candidate chromosomal regions for type 2 diabetes reveals a susceptibility locus on human chromosome 8p23.1.

S. Rich, T. Klupa, A. Krolewski, 2004, Diabetes.

Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus

Marc Montminy, M. Małecki, M. Saad, 1999, Nature Genetics.

Hypertension, orthostatic hypotension and the microvascular complications of diabetes.

A. Krolewski, J. Warram, A. Cupples, 1985, Journal of chronic diseases.

The changing natural history of nephropathy in type I diabetes.

A. Krolewski, C. R. Kahn, J. Warram, 1985, The American journal of medicine.

Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study

L. Rand, A. Krolewski, C. R. Kahn, 1986, Diabetes Care.

Multiple factors in the prediction of risk of proliferative diabetic retinopathy.

L. Rand, A. Krolewski, J. Warram, 1985, The New England journal of medicine.

Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes

T. Klupa, K. Wanic, J. Sieradzki, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23.

S. Weremowicz, S. Rich, A. Krolewski, 2004, Diabetes.

Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q.

S. Rich, A. Krolewski, A. Doria, 1999, Diabetes.

New Susceptibility Locus for NIDDM Is Localized to Human Chromosome 20q

S. Rich, A. Krolewski, J. Warram, 1997, Diabetes.

Genome-wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes Mellitus

A. Paterson, S. Bull, J. Klein, 2009 .

Familial factors determine the development of diabetic nephropathy in patients with IDDM

A. Krolewski, J. Warram, M. C. Angelico, 1996, Diabetologia.

Differences in Risk of Insulin-Dependent Diabetes in Offspring of Diabetic Mothers and Diabetic Fathers

A. Krolewski, C. R. Kahn, J. Warram, 1984 .

Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study.

D. Moczulski, A. Krolewski, J. Warram, 1998, Hypertension.

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes

K. Wanic, A. Krolewski, J. Dunn, 2008, Diabetes.

TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants.

A. Krolewski, J. Warram, D. Ng, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Epidemiologic approach to the etiology of type I diabetes mellitus and its complications.

J. Flier, L. Rand, A. Krolewski, 1987, The New England journal of medicine.

Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect.

S. Rich, T. Klupa, M. Małecki, 2002, Diabetes care.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

T. Mayadas, X. Cullere, J. Skupień, 2012, Journal of the American Society of Nephrology : JASN.

The metabolism of estradiol; oral compared to intravenous administration.

C. Longcope, B. Goldin, J. Warram, 1985, Journal of steroid biochemistry.

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes

C. Forsblom, P. Groop, J. Skupień, 2012, Diabetes Care.

Molecular methods for the study of the genetic determinants of nephropathy in type 1 (insulin-dependent) diabetes

A. Krolewski, A. Doria, J. Warram, 1992, Acta Diabetologica.

Segregation analysis of urinary albumin excretion in families with type 2 diabetes.

S. Rich, A. Krolewski, J. Warram, 2000, Diabetes.

Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women.

J. Dwyer, H. Adlercreutz, B. Goldin, 1982, The New England journal of medicine.

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

J. Bonventre, A. Krolewski, V. Vaidya, 2011, Kidney international.

Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs.

A. Krolewski, J. Warram, M. B. Freire, 1996, Endocrinology and metabolism clinics of North America.

Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.

A. Krolewski, J. Warram, L. Canani, 2005, Advances in chronic kidney disease.

Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.

D. Moczulski, A. Krolewski, J. Warram, 2000, Kidney international.

Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus.

S. Zarich, A. Krolewski, J. Warram, 1991, American heart journal.

Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program

Michael S. Reidy, Bartholomew E. Clark, Denise R. Anderson, 2012, PLoS genetics.

Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.

A. Galecki, J. Skupień, K. Duffin, 2017, Kidney international.

Different determinants of neovascularization on the optic disc and on the retina in patients with severe nonproliferative diabetic retinopathy.

L. Rand, A. Krolewski, J. Warram, 1993, Archives of ophthalmology.

Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene

A. Krolewski, A. Doria, J. Warram, 1994, Diabetes.

Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy

Stephen S. Rich, Josyf C. Mychaleckyj, G. David Poznik, 2009, Diabetes.

A Genome-Wide Linkage Scan for Genes Controlling Variation in Renal Function Estimated by Serum Cystatin C Levels in Extended Families With Type 2 Diabetes

R. Duggirala, S. Rich, S. Puppala, 2006, Diabetes.

Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes.

G. Gearin, A. Krolewski, A. Doria, 1996, Hypertension.

A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes.

D. Moczulski, R. Duggirala, S. Rich, 2006, Kidney international.

Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.

C. Langefeld, S. Rich, T. Klupa, 2000, Diabetes.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, American Society of Nephrology. Clinical Journal.

Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure.

S. Rich, A. Krolewski, J. Warram, 2000, Kidney international.

Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus

D. Moczulski, L. Scott, S. Rich, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Confirmation of Genetic Associations at ELMO 1 in the GoKinD Collection Support its Role as a Susceptibility Gene in Diabetic Nephropathy Short running title : ELMO 1 and susceptibility of nephropathy

S. Rich, J. Skupień, A. Krolewski, 2009 .

Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.

D. Moczulski, A. Krolewski, J. Warram, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in Type I diabetes mellitus

A. Krolewski, S. Araki, J. Warram, 2000, Diabetologia.

Scrutiny of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) locus reveals conserved haplotype block structure not associated with diabetic nephropathy.

K. Chia, A. Krolewski, W. Walker, 2004, Diabetes.

The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.

K. Wanic, M. Małecki, Jiang Hu, 2010, The Journal of clinical investigation.

Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes.

A. Krolewski, J. Warram, L. Canani, 2002, Diabetes.

The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus

L. Scott, M. Zychma, A. Krolewski, 1998, Diabetologia.

Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.

A. Krolewski, J. Warram, T. Onuma, 1998, Hypertension.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Angiotensin I-converting enzyme (ACE): estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots

S. Rich, A. Krolewski, A. Doria, 1994, Human Genetics.

Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan.

Ron Korstanje, Andrzej S Krolewski, Rong Yuan, 2010, Kidney international.

Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset.

A. Krolewski, J. Warram, J. Rogus, 2002, Diabetes.

Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

L. Wyrwicz, B. Krolewski, A. Krolewski, 2003, Journal of the American Society of Nephrology : JASN.

Trinucleotide Repeats at the rad Locus: Allele Distributions in NIDDM and Mapping to a 3-cM Region on Chromosome 16q

S. Weremowicz, C. Morton, A. Krolewski, 1995, Diabetes.

Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs.

A. Krolewski, J. Kopczyński, J. Warram, 1997, Endocrinology and metabolism clinics of North America.

Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.

A. Krolewski, R. Pop-Busui, J. Warram, 2015, Clinical journal of the American Society of Nephrology : CJASN.

New Polymorphism of ENPP1 (PC-1) Is Associated With Increased Risk of Type 2 Diabetes Among Obese Individuals

K. Wanic, J. Sieradzki, M. Małecki, 2006, Diabetes.

Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians.

A. Doria, J. Warram, V. Trischitta, 2002, The Journal of clinical endocrinology and metabolism.

Familial Clustering of Insulin Sensitivity

B. Rosner, S. Rich, A. Krolewski, 1992, Diabetes.

Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia.

L. Scott, A. Krolewski, L. Laffel, 2000, Diabetes.

Natural History of Impaired Glucose Tolerance: Follow‐up at Joslin Clinic

R. Sigal, A. Krolewski, J. Warram, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies

A. Krolewski, J. Meigs, J. Warram, 2002, Diabetic medicine : a journal of the British Diabetic Association.

Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes

R. Klein, T. Ahluwalia, D. Tregouet, 2021, Journal of the American Society of Nephrology : JASN.

Survival of breast cancer patients related to incidence risk factors

A. Morrison, C. Lowe, B. Macmahon, 1972, International journal of cancer.

Determinants of IDDM and Perinatal Mortality in Children of Diabetic Mothers

A. Krolewski, C. R. Kahn, J. Warram, 1988, Diabetes.

Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM

A. Krolewski, A. Doria, J. Warram, 1997, Diabetologia.

Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15.

L. Almasy, R. Duggirala, A. Krolewski, 2008, Atherosclerosis.

Risk of Early-Onset Proliferative Retinopathy in IDDM Is Closely Related to Cardiovascular Autonomic Neuropathy

M. Pfeifer, L. Rand, J. Warram, 1992, Diabetes.

A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

L. Scott, A. Krolewski, L. Laffel, 2001, Diabetes.

Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired?

A. Krolewski, J. Warram, D. Fogarty, 1998, Diabetes research and clinical practice.

Risk Factors for Progression of Background Retinopathy in Long-Standing IDDM

L. Rand, A. Krolewski, J. Warram, 1989, Diabetes.

Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin.

T. Klupa, J. Sieradzki, M. Małecki, 1999, European journal of endocrinology.

DdeI polymorphism in the AGTR1 gene.

A. Krolewski, A. Doria, J. Warram, 1994, Human molecular genetics.

Four RSAI restriction fragment melting polymorphisms in the region of the insulin receptor gene encoding for the alpha subunit

A. Krolewski, A. Doria, J. Warram, 1993, Clinical Genetics.

Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM.

A. Krolewski, L. Laffel, J. Warram, 1992, Kidney international.

High-frequency DNA sequence polymorphisms in the insulin receptor gene detected by denaturing gradient gel blots.

D. Housman, V. Stanton, B. Krolewski, 1992, Genomics.

A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents

J. Warram, P. Veng-Pedersen, C. -. Lin, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

Michael S. Reidy, Tanya M. Teslovich, Anne W. Ndungu, 2023, Diabetologia.

Hepatocyte nuclear factor-4gamma: cDNA sequence, gene organization, and mutation screening in early-onset autosomal-dominant type 2 diabetes.

G. Ryffel, A. Antonellis, A. Krolewski, 1999, Diabetes.

Usual dietary intake and hemoglobin A1 level in patients with insulin-dependent diabetes.

A. Krolewski, J. Warram, T. Shimakawa, 1993, Journal of the American Dietetic Association.

Risk of IDDM in Children of Diabetic Mothers Decreases With Increasing Maternal Age at Pregnancy

A. Krolewski, J. Warram, B. Martin, 1991, Diabetes.

Genetics of diabetic nephropathy: how far are we from finding susceptibility genes?

A. Krolewski, J. Warram, L. Canani, 2001, Advances in nephrology from the Necker Hospital.

To: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426–428

A. Krolewski, J. Warram, D. Ng, 2003, Diabetologia.

Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.

A. Krolewski, S. Araki, J. Warram, 2001, Diabetologia.

Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2012, American journal of physiology. Renal physiology.

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline

K. Wanic, W. Ju, M. Kretzler, 2013, PloS one.

Genetic susceptibility to diabetic nephropathy.

A. Krolewski, L. Laffel, J. Warram, 1992, Advances in nephrology from the Necker Hospital.

Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes.

A. Doria, J. Warram, T. Hauser, 2008, JAMA.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

J. Skupień, A. Krolewski, J. Warram, 2011, Journal of the American Society of Nephrology : JASN.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Risk for Cardiovascular Autonomic Neuropathy Is Associated with the HLA-DR3/4 Phenotype in Type I Diabetes Mellitus

M. Pfeifer, L. Rand, A. Krolewski, 1992, Annals of Internal Medicine.

Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.

C. Langefeld, S. Rich, T. Klupa, 2000, Diabetes.

Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene

A. Krolewski, A. Doria, J. Warram, 1994, Diabetes.

Cardiovascular autonomic neuropathy and proliferative diabetic retinopathy.

A. Krolewski, J. Warram, Lloyd M. Aiello, 1995, American journal of ophthalmology.